Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Net Current Assets

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Current Assets (Including Current Investments) ₹5,918 Cr₹5,218 Cr₹4,247 Cr₹6,172 Cr₹5,270 Cr

What is the latest Net Current Assets ratio of GLAND PHARMA ?

The latest Net Current Assets ratio of GLAND PHARMA is ₹5,918 Cr based on Mar2026 Consolidated results.
Year Net Current Assets
Mar2026₹5,918 Cr
Mar2025₹5,218 Cr
Mar2024₹4,247 Cr
Mar2023₹6,172 Cr
Mar2022₹5,270 Cr

How is Net Current Assets of GLAND PHARMA Trending?

Years Net Current Assets % Change
Mar2026 ₹5,918 Cr
13.42
Mar2025 ₹5,218 Cr
22.87
Mar2024 ₹4,247 Cr
-31.19
Mar2023 ₹6,172 Cr
17.11
Mar2022 ₹5,270 Cr -

Compare Net Current Assets of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹51,581.5 Cr 3.4% 0.6% 63.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,497.0 Cr 5.2% 4.3% 8% Stock Analytics
DIVIS LABORATORIES ₹294,146.0 Cr 3.6% 7.6% 50.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,474.0 Cr 3.4% 0.7% 32.6% Stock Analytics
DR REDDYS LABORATORIES ₹114,349.0 Cr 2.3% 14% 13.6% Stock Analytics
CIPLA ₹113,989.0 Cr 2% 6% -6.7% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

3.4%

0.6%

63.1%

SENSEX

7%

11.5%

-3.5%


You may also like the below Video Courses